Thirona lands €7.5M to scale its AI lung-imaging platform
What's the deal? Nijmegen-based ThironaDealroom has a profile for this one. Try Dealroom → has raised €7.5M in an early-stage round to advance AI-powered analysis of thoracic CT images. The round combines a €5M investment from HERAN PartnersDealroom has a profile for this one. Try Dealroom → and Dutch-based Borski FundDealroom has a profile for this one. Try Dealroom → with a €2.5M grant from the European Innovation Council.
What does it do? Founded by scientist Eva van RikxoortDealroom has a profile for this one. Try Dealroom → in 2014, Thirona specialises in precise image analysis of retinal and lung images for medtech, pharmaceutical, and contract research companies. Its lung quantification platform, LungQ, runs AI algorithms trained on disease-specific datasets and has analysed over 15 million images.
What's the endgame? Thirona says the money will accelerate adoption of its innovations for precision medicine. The company claims its technology can improve the precision of bronchoscopic and surgical lung procedures, including robotic ones, making them less invasive for patients.
Why it matters? "Thirona has achieved major growth milestones, forged co-innovation partnerships with leading medical companies, and became a leader in the MedTech space for lung image analysis," said Simone BrummelhuisDealroom has a profile for this one. Try Dealroom → of Borski Fund. The fund focuses on improving access to financing for female entrepreneurs.
Image credit: Pulmonary Pathology
